The "dying-back" phenomenon of motor neurons in ALS
- PMID: 21057983
- DOI: 10.1007/s12031-010-9467-1
The "dying-back" phenomenon of motor neurons in ALS
Abstract
Amyotrophic lateral sclerosis (ALS) is a lethal disease, characterized by progressive death of motor neurons with unknown etiology. Evidence from animal models indicates that neuronal dysfunction precedes the clinical phase of the disease. However, in parallel extensive nerve sprouting and synaptic remodeling as part of a compensatory reinnervation processes and possibly also of motor neurons pathology was demonstrated. Therefore, the weakness in muscle groups will not be clinically apparent until a large proportion of motor units are lost. This motor unit loss and associated muscle function which precedes the death of motor neurons may resemble the "die-back" phenomena. Studies indicated that in the early stages the nerve terminals and motor neuron junctions are partially degraded while the cell bodies in the spinal cord are mostly intact. Treatments to rescue motor neurons according to "dying-forward" model of motor neuron pathology in ALS have shown only limited success in SOD1(G93A) transgenic mice as well as in humans. If cell body degeneration is late compared with axonal degeneration, early intervention could potentially prevent loss of motor neurons. Therefore, it should be considered, according to the dying back hypothesis, to focus on motor neurons terminals in order to delay or prevent the progressive degradation.
Similar articles
-
Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.J Chem Neuroanat. 2016 Oct;76(Pt A):35-47. doi: 10.1016/j.jchemneu.2016.03.003. Epub 2016 Mar 30. J Chem Neuroanat. 2016. PMID: 27038603
-
Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.Neurobiol Dis. 2007 Nov;28(2):154-64. doi: 10.1016/j.nbd.2007.07.003. Epub 2007 Jul 10. Neurobiol Dis. 2007. PMID: 17766128
-
Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.Neuroscience. 2014 Sep 26;277:132-8. doi: 10.1016/j.neuroscience.2014.03.047. Epub 2014 Mar 31. Neuroscience. 2014. PMID: 24699224
-
[Cortical Motor Neuron Hyperexcitability and Motor Neuron Death in ALS: Dying Forward Hypothesis].Brain Nerve. 2017 May;69(5):565-569. doi: 10.11477/mf.1416200783. Brain Nerve. 2017. PMID: 28479534 Review. Japanese.
-
Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis.J Physiol Paris. 2006 Mar-May;99(2-3):211-20. doi: 10.1016/j.jphysparis.2005.12.014. Epub 2006 Jan 30. J Physiol Paris. 2006. PMID: 16448809 Review.
Cited by
-
Promising application of a new ulnar nerve compound muscle action potential measurement montage in amyotrophic lateral sclerosis: a prospective cross-sectional study.Neural Regen Res. 2023 Apr;18(4):908-912. doi: 10.4103/1673-5374.353499. Neural Regen Res. 2023. PMID: 36204862 Free PMC article.
-
Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis.Biomed Res Int. 2016;2016:5930621. doi: 10.1155/2016/5930621. Epub 2016 Apr 18. Biomed Res Int. 2016. PMID: 27195289 Free PMC article.
-
Arginine Methyltransferase PRMT8 Provides Cellular Stress Tolerance in Aging Motoneurons.J Neurosci. 2018 Aug 29;38(35):7683-7700. doi: 10.1523/JNEUROSCI.3389-17.2018. Epub 2018 Jul 27. J Neurosci. 2018. PMID: 30054395 Free PMC article.
-
Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9.Elife. 2018 Aug 23;7:e36892. doi: 10.7554/eLife.36892. Elife. 2018. PMID: 30136928 Free PMC article.
-
The ALS-inducing factors, TDP43A315T and SOD1G93A, directly affect and sensitize sensory neurons to stress.Sci Rep. 2018 Nov 8;8(1):16582. doi: 10.1038/s41598-018-34510-8. Sci Rep. 2018. PMID: 30410094 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous